Table 2 Descriptions of the dermal excisions taken for this study
Group | Treatment | Study period (biopsy samples taken) | ||
|---|---|---|---|---|
7 day | 14 day | 28 day | ||
CA | 500 mg/day | 3 | 3 | 3 |
TA1 | 500 mg/day | 3 | 3 | 3 |
TA2 | 500 mg/day | 3 | 3 | 3 |
TA3 | 500 mg/day | 3 | 3 | 3 |
Normal skin | None | None | None | 3 |
Group | Treatment | Study period (biopsy samples taken) | ||
|---|---|---|---|---|
7 day | 14 day | 28 day | ||
CA | 500 mg/day | 3 | 3 | 3 |
TA1 | 500 mg/day | 3 | 3 | 3 |
TA2 | 500 mg/day | 3 | 3 | 3 |
TA3 | 500 mg/day | 3 | 3 | 3 |
Normal skin | None | None | None | 3 |